Robert A. Hegele

Robert A. Hegele MD FRCPC Cert Endo FACP FCAHS FAHA Jacob J. Wolfe Distinguished Medical Research Chair Martha Blackburn Chair in Cardiovascular Research Distinguished University Professor of Medicine and Biochemistry Scientist, Robarts Research Institute University of Western Ontario Rob Hegele cares for >2800 patients in his lipid clinic at University Hospital in London, Ontario. His laboratory discovered the causal genes for >20 human diseases and also developed the world’s first targeted next-generation sequencing panel for dyslipidemias. He is also known for characterizing the polygenic basis of human lipid disorders. He was among the first in the world to use five medications that are now routinely prescribed to treat dyslipidemia or diabetes. He has published 960 papers with >88,000 citations on Google Scholar and is in the top 1% of highly cited scientists in the world. The website Expertscape.com in 2023 ranked him #1 globally in the area of “hypertriglyceridemia” and #2 for “disorders of lipid metabolism”. He received the 2019 American Heart Association Lyman Duff Award, the 2020 FH Foundation Pioneer Award, and 2024 US National Lipid Association Virgil Brown Distinguished Achievement Award. He has co-authored many clinical practice guidelines for cholesterol, blood pressure, and diabetes. He has trained numerous physicians, medical students, and graduate students.